Vincristine Dose Adjustment for Abnormal Liver Function Tests

Dose Adjustment Guidelines Based on Liver Function

For patients with ALT/AST levels less than 3× ULN, no dose adjustment is required, but increased monitoring is recommended, as per the Alimentary Pharmacology and Therapeutics guidelines 1
For patients with ALT/AST levels between 3-5× ULN, consider monitoring more frequently, according to the Alimentary Pharmacology and Therapeutics guidelines 1
For patients with ALT/AST levels greater than 5× ULN, consider temporary hold until improvement, as recommended by the Alimentary Pharmacology and Therapeutics guidelines 1

Obtain baseline liver function tests before initiating vincristine therapy, as recommended by the Alimentary Pharmacology and Therapeutics guidelines 1
Monitor liver function before each cycle of vincristine, according to the Alimentary Pharmacology and Therapeutics guidelines 1
Increase monitoring frequency when liver test elevations are detected, as per the Alimentary Pharmacology and Therapeutics guidelines 1

If liver function returns to baseline or near baseline, consider reintroducing vincristine at a reduced dose, as recommended by the Alimentary Pharmacology and Therapeutics guidelines 1
Rechallenge is not recommended when there is no evidence of benefit for the patient or when alternative treatment options with less hepatotoxicity are available, according to the Alimentary Pharmacology and Therapeutics guidelines 1

Using the same action thresholds for patients with normal and abnormal baseline liver function is inadequate, as stated by the Alimentary Pharmacology and Therapeutics guidelines 1